Er-Kim to distribute Puma’s Nerlynx in Central Asian, Eastern European countries
Pharmaceutical company Er-Kim has entered into an agreement with Puma Biotechnology for the distribution of the latter’s Nerlynx (neratinib), aimed at treating breast cancer, in certain Central Asian and Eastern European countries. This agreement …